acp obesity guideline semaglutide

acp obesity guideline semaglutide

Is Semaglutide the Key to Obesity Care?

Semaglutide is now recommended as a first-line pharmacologic option for adults with a BMI ≥ 30, making it a central tool in obesity care. Did you know 65% of eligible obese patients never receive a GLP-1 prescription? The American College of Physicians (ACP) just released a guideline that could change that